Literature DB >> 15322026

A Salmonella fim homologue in Citrobacter freundii mediates invasion in vitro and crossing of the blood-brain barrier in the rat pup model.

Petra Hess1, Artur Altenhöfer, A Salam Khan, Neda Daryab, Kwang Sik Kim, Jörg Hacker, Tobias A Oelschlaeger.   

Abstract

From the invasive Citrobacter freundii strain 3009, an invasion determinant was cloned, sequenced, and expressed. Sequence analysis of the determinant showed high homology with the fim determinant from Salmonella enterica serovar Typhimurium. The genes of the invasion determinant directed invasion of recombinant Escherichia coli K-12 strains into human epithelial cell lines of the bladder and gut as well as mannose-sensitive yeast agglutination and were termed fim(Cf) genes. Expression of the Fim(Cf) proteins was shown by (35)S labeling and/or Western blotting. In the infant rat model of experimental hematogenous meningitis, C. freundii strain 3009 and the in vitro invasive recombinant E. coli K-12 strain harboring the fim(Cf) determinant reached the cerebrospinal fluid, in contrast to the case for the control strain. The fim determinant was also necessary for efficient in vitro invasion by C. freundii, because a deletion mutant was strongly reduced in its invasion efficiency. The mutation could be complemented in trans by the corresponding genes. Invasion by C. freundii could be blocked only by d-mannose, GlcNAc, and chitin hydrolysate and not by other carbohydrates tested. In contrast, yeast agglutination was not affected by GlcNAc or chitin hydrolysate. This finding indicated mannose residues to be essential for both yeast agglutination and invasion, whereas GlcNAc (oligomer) residues of host cells are involved exclusively in invasion. These results showed the fim determinant of C. freundii to be responsible for d-mannose- and GlcNAc-dependent in vitro invasion without being assembled into pili and for crossing of the blood-brain barrier in the infant rat model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322026      PMCID: PMC517473          DOI: 10.1128/IAI.72.9.5298-5307.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.

Authors:  M A Mulvey; Y S Lopez-Boado; C L Wilson; R Roth; W C Parks; J Heuser; S J Hultgren
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

2.  Adhesion to and invasion of HeLa cells by pathogenic Escherichia coli carrying the afa-3 gene cluster are mediated by the AfaE and AfaD proteins, respectively.

Authors:  M Jouve; M I Garcia; P Courcoux; A Labigne; P Gounon; C Le Bouguénec
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Type 1C fimbriae of a uropathogenic Escherichia coli strain: cloning and characterization of the genes involved in the expression of the 1C antigen and nucleotide sequence of the subunit gene.

Authors:  I van Die; B van Geffen; W Hoekstra; H Bergmans
Journal:  Gene       Date:  1985       Impact factor: 3.688

5.  F17-like fimbriae from an invasive Escherichia coli strain producing cytotoxic necrotizing factor type 2 toxin.

Authors:  K el Mazouari; E Oswald; J P Hernalsteens; P Lintermans; H De Greve
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Measurement of invasion by gentamicin resistance.

Authors:  E A Elsinghorst
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

7.  Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system.

Authors:  F W Studier
Journal:  J Mol Biol       Date:  1991-05-05       Impact factor: 5.469

8.  Cloning and characterization of the S fimbrial adhesin II complex of an Escherichia coli O18:K1 meningitis isolate.

Authors:  J Hacker; H Kestler; H Hoschützky; K Jann; F Lottspeich; T K Korhonen
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Molecular considerations in the evolution of bacterial genes.

Authors:  J G Lawrence; D L Hartl; H Ochman
Journal:  J Mol Evol       Date:  1991-09       Impact factor: 2.395

10.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

View more
  5 in total

Review 1.  Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek.

Authors:  Sean-Paul Nuccio; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

2.  Multiple low-dose infusions of human umbilical cord blood cells improve cognitive impairments and reduce amyloid-β-associated neuropathology in Alzheimer mice.

Authors:  Donna Darlington; Juan Deng; Brian Giunta; Huayan Hou; Cyndy D Sanberg; Nicole Kuzmin-Nichols; Hua-Dong Zhou; Takashi Mori; Jared Ehrhart; Paul R Sanberg; Jun Tan
Journal:  Stem Cells Dev       Date:  2012-09-05       Impact factor: 3.272

3.  How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains.

Authors:  Elzbieta Brzuszkiewicz; Holger Brüggemann; Heiko Liesegang; Melanie Emmerth; Tobias Olschläger; Gábor Nagy; Kaj Albermann; Christian Wagner; Carmen Buchrieser; Levente Emody; Gerhard Gottschalk; Jörg Hacker; Ulrich Dobrindt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-15       Impact factor: 11.205

4.  The lrp gene and its role in type I fimbriation in Citrobacter rodentium.

Authors:  Angela Cordone; Emilia M F Mauriello; Derek J Pickard; Gordon Dougan; Maurilio De Felice; Ezio Ricca
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

5.  Genetic characterization of atypical Citrobacter freundii.

Authors:  Gabriela Delgado; Valeria Souza; Rosario Morales; René Cerritos; Andrea González-González; José Luis Méndez; Virginia Vázquez; Alejandro Cravioto
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.